Rare diseases
Investigational molecules
Locations
Study on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
RomaniaStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
RomaniaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
RomaniaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
RomaniaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
RomaniaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
RomaniaGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
RomaniaStudy of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer
RomaniaA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
RomaniaEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RomaniaBioequivalence Study of Dapagliflozin 10 mg Tablets in Healthy Adult Volunteers with Diabetes
RomaniaPhase 3 Study of Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Metastatic NSCLC with PD-L1 TPS ≥50%
RomaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
